GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a prominent focus in therapeutic studies, largely due to its impressive impact on managing ailments such as second type diabetes and weight gain. Recent research have shown that beyond glucose management, GLP-1 drugs offer benefits for cardiovascular well-being and